Literature DB >> 9365378

Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study.

P Flachenecker1, H P Hartung, K Reiners.   

Abstract

Power spectrum analysis of heart rate variability was repeatedly carried out on 13 patients with Guillain-Barré syndrome for up to 1 year by Fourier analysis of regular beat-to-beat (R-R) intervals which were recorded for 5 min, converted into a continuous function by linear interpolation and resampled at 5 Hz. Low-frequency (LF) power (reflecting a mixture of parasympathetic and sympathetic activity) and high-frequency (HF) power (reflecting parasympathetic tone) were calculated by integrating the spectra from 0.04 to 0.15 Hz and from 0.15 to 0.4 Hz, respectively. At the height of the disease, the HF component was significantly decreased. The LF:HF ratio, which has been suggested to be an indicator for sympathetic activity, was increased compared with the follow-up value after 1 year. Both measures returned to normal gradually over time. Pooled-data analysis suggested that both HF and LF power were significantly related to the responses of standardized parasympathetic function tests, while the LF:HF ratio was inversely correlated with sympathetic vasomotor activity. In patients presenting with tachycardia, LF and HF power were strikingly decreased compared with patients with normal heart rates, while in patients showing vagal over-reactivity, the power of both spectral bands was significantly increased. The results suggest that spectral analysis of heart rate variability is useful for investigating the cardiovascular neural regulation in patients with Guillain-Barré syndrome. In this disorder, the sympathovagal balance is clearly shifted to sympathetic predominance at the height of the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9365378     DOI: 10.1093/brain/120.10.1885

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  10 in total

1.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.

Authors:  Cheng-Yin Tan; Nortina Shahrizaila; Kee-Ying Yeoh; Khean-Jin Goh; Maw-Pin Tan
Journal:  Clin Auton Res       Date:  2018-04-13       Impact factor: 4.435

3.  Long-term outcome of Guillain-Barré syndrome.

Authors:  S Koeppen; K Kraywinkel; T E Wessendorf; C E Ehrenfeld; M Schürks; H C Diener; C Weimar
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Intrapulmonary right-left shunts in Guillain-Barré syndrome with severe dysautonomia.

Authors:  Marek Sykora; Jennifer Diedler; Werner Hacke; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 5.  Autonomic involvement in Guillain-Barré syndrome: an update.

Authors:  Zoya Zaeem; Zaeem A Siddiqi; Douglas W Zochodne
Journal:  Clin Auton Res       Date:  2018-07-17       Impact factor: 4.435

Review 6.  Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis.

Authors:  Peter Flachenecker
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

7.  Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes.

Authors:  Tia Chakraborty; Christopher L Kramer; Eelco F M Wijdicks; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

8.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

9.  Heart rate variability analysis in general medicine.

Authors:  Yi Gang; Marek Malik
Journal:  Indian Pacing Electrophysiol J       Date:  2003-01-01

10.  Acute idiopathic polyradiculoneuritis with secondary arterial hypertension in a 5-year-old male Siberian Husky.

Authors:  Mihai Musteata; Raluca Ștefănescu; Andrei Radu Baisan; Diana Mocanu; Sorin Aurelian Pașca; Luminița Diana Hrițcu; Mădălina Henea; Gheorghe Solcan
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.